Show results for
Refine by
Immunotherapeutics Equipment & Supplies In Oman
124 equipment items found
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous vaccine models used ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Ombipepimut-S Emulsion (DSP-7888) is an investigational immunotherapeutic cancer vaccine containing 2 peptides that induce WT1-specific cytotoxic T lymphocytes (WT1-CTLs) and helper T cells to attack WT1-expressing cancerous cells found in various types of hematologic malignancies and solid tumors.1,2 Researchers have identified that adding helper T-cell–inducing peptides ...
Manufactured by:IDT Biologika based inDessau-Rosslau, GERMANY
IDT Biologika is a leading viral vector CDMO with an exceptional track record in biologics manufacturing, including expertise with live viral agents. This makes us well-positioned to support the rapid growth in gene therapy and immunotherapeutics markets and the huge demand for transformative viral ...
Manufactured by:Dia.Pro Diagnostic Bioprobes s.r.l based inSesto San Giovanni, ITALY
The IgG assay is intended for testing: (a) health-care workers at risk of COVID-19 infection to verify whether or not they might be positive for potentially neutralizing anti Spike IgG; (b) normal population for epidemiology studies on presence of potential “protective” IgG to COVID-19 Spike antigens; (c) PCR-negative infected individuals, successfully recovered from infection, to ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Liquid, ready-to-use subcutaneous immunoglobulin (SCIg). ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Liquid, ready-to-use subcutaneous immunoglobulin ...
by:Metaclipse Therapeutics Corporation based inAtlanta, GEORGIA (US) (USA)
Influenza (Target age 65+) and Influenza+ SARS-C0V-2 ...
Manufactured by:Transgene based inIllkirch-Graffenstaden, FRANCE
A particularly innovative immunotherapy, TG4050 is the lead myvac® candidate. This individualized treatment is based on the specific mutations that are identified in each patient’s ...
Manufactured by:AJ Vaccines A/S based inKøbenhavn, DENMARK
VesiCulture (BCG Culture) For the treatment of Bladder ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
PEPI Panel – A unique approach for personalized cancer immunotherapy generation. Our Peptide Library (PEPI Panel) currently contains 3,286 proprietary, immunogenic peptide fragments from 184 tumor antigens associated with 19 cancer indications that induce immune responses in the largest subpopulation of subjects, based on HLA genotype (both class I and II) of 16,000 subjects. PEPI Panel ...
Manufactured by:Allergy Therapeutics based inWest Sussex, UNITED KINGDOM
We are proud to offer a wide range of pioneering aluminium-free allergy vaccines and diagnostics. Our short course of treatments are efficient, effective and convenient. As a healthcare professional, you understand the importance of convenience in allergy treatments, because this allows you to deliver the best patient care. Through quality Specific Immunotherapy products, you can manage your time ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Liquid, ready-to-use intravenous immunoglobulin (IVIg). Indication: To treat patients that require replacement of antibodies to help provide protection against some infections. For treatment of some autoimmune disorders (diseases where the immune system is overactive). Panzyga® can only be obtained on a doctor’s ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
octagam® 5% (50 mg/ml), Human Normal Immunoglobulin. octagam® 10% (100 mg/ml), Human Normal Immunoglobulin. Liquid, ready-to-use intravenous immunoglobulin ...
by:Calviri based inPhoenix, ARIZONA (USA)
Calviri’s immunotherapy diagnostic is a huge leap forward in predicting therapy outcomes compared to current available ...
Manufactured by:Enterome based inParis, FRANCE
EO2401 is an innovative, off-the-shelf immunotherapy discovered by ...
Manufactured by:Dia.Pro Diagnostic Bioprobes s.r.l based inSesto San Giovanni, ITALY
Chemi-Luminescence ImmunoAssay (CLIA) for the serological determination of the neutralization activity of antibodies to SARS-CoV-2, induced by natural infection and/or vaccination, able to block the interaction of Receptor Binding Domain (RBD) and ACE2 and thus the virus ...
Manufactured by:Dia.Pro Diagnostic Bioprobes s.r.l based inSesto San Giovanni, ITALY
Module-based Enzyme-Immuno-Assay (ELISA) for the confirmation of samples positive for IgG and IgM antibodies to COVID-19 in first screening. The test is particularly useful in monitoring patients, infected by COVID-19, from the time of symptoms offset up to full recovery. The test can be used in addition to identify (a) the specificity (“typing”) of antibodies to the major ...
by:National Resilience, Inc. based inSan Diego, CALIFORNIA (USA)
Innovators in immunotherapy, stem cell therapy, and regenerative medicine will find like-minded champions at ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso5 is a discovery-stage program leveraging a specific keystone gut bacteria (undisclosed) to potentiate the effects of Immune Checkpoint Blockade (ICB) drugs. The field of cancer therapy has been revolutionized by the use of immunotherapy. The microbiome breakthrough science today paves the way for innovative biotherapies to potentiate the effectiveness of these cancer immunotherapies. YSOPIA ...
by:Enveric Biosciences, Inc. based inNaples, FLORIDA (USA)
Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies. Preclinical data suggests combination therapies may improve the activity of certain chemotherapies or cancer immunotherapies, potentially enabling more potent or longer-lasting therapeutic effects. In addition, combination therapies may allow for the same or greater therapeutic effect ...